Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of TNX-1900 in chronic migraine has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• TNX-1900

Snippet

Sponsor: Tonix Pharmaceuticals, Inc. | Conditions: Chronic Migraine, Chronic Migraine, Headache | Phase 2 | Status: COMPLETED | Results posted: 2025-02-25